Head-to-head · WeighScore
Ark Health vs Kin Meds
The verdict
Kin Meds takes it — 72.9/100 to 56.8/100.
Kin Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection and…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Ark Health | Kin Meds |
|---|---|---|
| WeighScore | 56.8/100 | 72.9/100 |
| Grade | C | C |
| Scorecard rank | #407 | #75 |
| Semaglutide | $1,399/mo (brand Ozempic) | $149/mo (brand Wegovy) |
| Tirzepatide | $1,499/mo (brand Mounjaro) | $149/mo (brand Zepbound) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Graded #407 · C
Strengths
- Broadest menu in the directory — compounded sema/tirz injection, oral sema, brand Ozempic and Mounjaro, Sermorelin, MIC/B12
- Consistent pricing at all dosages — flat rate, no escalation as you titrate up
- Compounded oral semaglutide at $125/mo is competitive for a niche most providers don't offer
- Free expedited shipping included
- Phone support published (uncommon among DTC platforms)
Where it loses points
- States served not listed — can't confirm coverage in your state without contacting support
- LegitScript status not disclosed — no badge or verifiable ID
- FDA compounded-medication disclaimer not displayed
- Medical director / clinical lead not named — only generic 'certified healthcare providers'
- Pharmacy partner not named; 503A vs 503B unspecified
Graded #75 · C
Strengths
- Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
- Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
- LegitScript verified
- Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
- Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health
Where it loses points
- Legal entity name and state of incorporation not publicly disclosed
- The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
- Per-state availability not listed
- $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
- Lab work and dose-titration support not clearly described
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.